about
Lifetime risk of esophageal adenocarcinoma in patients with Barrett's esophagus.Barrett's oesophagus: Evidence from the current meta-analyses.Surgical treatments for esophageal cancers.Splenectomy for non-haematological metastatic malignant disease.Cancer prevention in Europe: the Mediterranean diet as a protective choice.Projections for oesophageal cancer incidence in England to 2033.Barrett's esophagus registries.Mortality in Barrett's esophagus: three decades of experience at a single center.Comparative genomic analysis of esophageal cancers.Aspirin is not chemoprotective for Barrett's adenocarcinoma of the oesophagus in multicentre cohort.The relationship between smoking and severe dysplastic disease in patients with Barrett's columnar-lined oesophagus.Routinely diagnosed low-grade dysplasia in Barrett's oesophagus: a population-based study of natural history.Are newly diagnosed columnar-lined oesophagus patients getting younger?Barrettʼs, blood groups and progression to oesophageal cancerThe influence of symptom type and duration on the fate of the metaplastic columnar-lined Barrett's oesophagusSmall bowel obstruction from laparoscopic adjustable gastric banding connecting tubeRadiofrequency ablation of Barrett's oesophagus with confirmed low-grade dysplasia reduces risk of development of high-grade dysplasia and adenocarcinoma
P50
Q33948451-A42A3539-05D3-4420-B17D-49F77F90B4F3Q34047978-66CC9FE1-A323-4A18-B665-566E2283814CQ35256054-5E18FAF2-05B5-4D61-B7C2-72A6CEE62811Q37843850-E48AE499-A316-4737-9C3E-266055F7BBE6Q38014307-4B6652DE-2646-4878-8EF5-BE6E1A0569F3Q39769683-5EF924D6-3726-4028-8B95-BDD652C26450Q43468162-5582FC34-8EBD-4D4E-948F-345FB4B39751Q44446838-7B161311-5EDD-45B3-95FB-F9CFC55E4911Q44473333-09A000CF-C7B9-4D9F-96C1-03C0B85C07CAQ45924446-45469813-1D61-4869-92A0-086A94F5BFECQ48000162-076B1586-8ED8-4B13-9BAB-72BD677264C5Q51134905-AAD1AF80-3266-4F5E-97B8-7838C9B4507DQ51649903-FA2FFD91-3A24-4483-A104-F12FADD2F85FQ59342685-898AA4E3-79BD-4BB5-8052-3276EC50DD20Q83365059-050276D0-9E35-4690-B77C-BCB6CF92E38DQ86650364-0C1643C9-9AEB-43DB-8AA7-328F3FCB3212Q87375912-52BACBCB-1C47-4E4E-8911-6FDD99677FE7
P50
description
researcher, ORCID id # 0000-0002-1361-9940
@en
wetenschapper
@nl
name
Piers Gatenby
@ast
Piers Gatenby
@en
Piers Gatenby
@es
Piers Gatenby
@nl
type
label
Piers Gatenby
@ast
Piers Gatenby
@en
Piers Gatenby
@es
Piers Gatenby
@nl
prefLabel
Piers Gatenby
@ast
Piers Gatenby
@en
Piers Gatenby
@es
Piers Gatenby
@nl
P106
P31
P496
0000-0002-1361-9940